Rationale, design and objectives of ARegPKD, a European ARPKD registry study

被引：0

作者：

Kathrin Ebner

Markus Feldkoetter

Gema Ariceta

Carsten Bergmann

Reinhard Buettner

Anke Doyon

Ali Duzova

Heike Goebel

Dieter Haffner

Barbara Hero

Bernd Hoppe

Thomas Illig

Augustina Jankauskiene

Norman Klopp

Jens König

Mieczyslaw Litwin

Djalila Mekahli

Bruno Ranchin

Anja Sander

Sara Testa

Lutz Thorsten Weber

Dorota Wicher

Ayse Yuzbasioglu

Klaus Zerres

Jörg Dötsch

Franz Schaefer

Max Christoph Liebau

机构：

[1] University Hospital of Cologne,Department of Pediatrics

[2] University Hospital Bonn,Department of Pediatrics

[3] University Hospital Vall d’Hebron,Department of Pediatric Nephrology

[4] Bioscientia Center for Human Genetics,Renal Division, Department of Medicine

[5] University Freiburg Medical Center,Division of Pediatric Nephrology

[6] Institute of Pathology,Department of Pediatrics

[7] University Hospital of Cologne,Department of Pediatric Kidney

[8] University Children’s Hospital Heidelberg,Department of General Pediatrics

[9] Division of Pediatric Nephrology,Department of Pediatric Nephrology

[10] Hacettepe University Faculty of Medicine,Service de Néphrologie Pédiatrique, Hospices Civils de Lyon

[11] Liver and Metabolic Diseases,Institute of Medical Biometry and Informatics

[12] Hannover Medical School,Department of Medical Biology

[13] Hannover Unified Biobank,Institute of Human Genetics

[14] Hannover Medical School,Nephrology Research Laboratory, Department II of Internal Medicine

[15] Institute for Human Genetics,undefined

[16] Hannover Medical School,undefined

[17] Vilnius University Hospital,undefined

[18] Center for Pediatrics,undefined

[19] University Hospital Münster,undefined

[20] The Children’s Memorial Health Institute,undefined

[21] University Hospitals Leuven,undefined

[22] Université de Lyon,undefined

[23] Hôpital Femme Mère Enfant,undefined

[24] University of Heidelberg,undefined

[25] Pediatric Nephrology Unit,undefined

[26] Fondazione IRCCS Ca Granda Ospedale Maggiore Polic,undefined

[27] Center for Biobanking and Genomics,undefined

[28] Hacettepe University,undefined

[29] RWTH University Hospital Aachen,undefined

[30] Center for Molecular Medicine,undefined

[31] University Hospital of Cologne,undefined

[32] University Hospital of Cologne,undefined

来源：

BMC Nephrology | / 16卷

关键词：

ARPKD; Ciliopathy; PKHD1; Polycystic kidney disease; Congenital hepatic fibrosis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 189 条

[1] Ward CJ(2002)The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein Nat Genet 30 259-69
[2] Hogan MC(2011)Ciliopathies N Engl J Med 364 1533-43
[3] Rossetti S(2007)When cilia go bad: cilia defects and ciliopathies Nat Rev Mol Cell Biol 8 880-93
[4] Walker D(2011)Modeling human disease in humans: the ciliopathies Cell 147 70-9
[5] Sneddon T(2014)An emerging molecular understanding and novel targeted treatment approaches in pediatric kidney diseases Front Pediatr 2 68-40
[6] Wang X(2010)Everolimus in patients with autosomal dominant polycystic kidney disease N Engl J Med 363 830-9
[7] Hildebrandt F(2010)Sirolimus and kidney growth in autosomal dominant polycystic kidney disease N Engl J Med 363 820-18
[8] Benzing T(2012)Tolvaptan in patients with autosomal dominant polycystic kidney disease N Engl J Med 367 2407-95
[9] Katsanis N(2013)Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial Lancet 382 1485-96
[10] Fliegauf M(2014)Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 9 889-66

← 1 2 3 4 5 6 7 8 9 10 →